KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Zimmer Biomet Holdings (ZBH) Shares Outstanding (Weighted Average) (2022 - 2025)

Zimmer Biomet Holdings (ZBH) has 4 years of Shares Outstanding (Weighted Average) data on record, last reported at $175.2 million in Q2 2012.

  • For Q2 2012, Shares Outstanding (Weighted Average) fell 8.8% year-over-year to $175.2 million; the TTM value through Jun 2012 reached $175.2 million, down 8.8%, while the annual FY2011 figure was $187.6 million, 6.2% down from the prior year.
  • Shares Outstanding (Weighted Average) reached $175.2 million in Q2 2012 per ZBH's latest filing, down from $177.4 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $221.5 million in Q1 2009 and bottomed at $175.2 million in Q2 2012.
  • Average Shares Outstanding (Weighted Average) over 4 years is $198.8 million, with a median of $199.4 million recorded in 2010.
  • Peak YoY movement for Shares Outstanding (Weighted Average): decreased 4.08% in 2011, then fell 8.8% in 2012.
  • A 4-year view of Shares Outstanding (Weighted Average) shows it stood at $215.0 million in 2009, then decreased by 6.98% to $200.0 million in 2010, then dropped by 6.2% to $187.6 million in 2011, then decreased by 6.61% to $175.2 million in 2012.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Weighted Average) were $175.2 million in Q2 2012, $177.4 million in Q1 2012, and $187.6 million in Q4 2011.